Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) just unveiled an announcement.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has declared a final ordinary cash dividend of RMB 0.5 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 22 May 2026. The dividend, to be paid in Hong Kong dollars with the exact HKD amount and exchange rate still to be announced, will have an ex-dividend date of 27 May 2026 and is expected to be paid on 31 July 2026.
The record date for determining shareholder entitlement is set for 2 June 2026, with share registration closing from 29 May to 2 June 2026 and handled by Tricor Investor Services Limited in Hong Kong. Details of any withholding tax on the dividend have yet to be announced, leaving investors to await further clarification on the net payout, but the declaration underscores the company’s intent to return cash to shareholders and may signal confidence in its financial performance for 2025.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a Hong Kong-listed medical technology company focused on developing and supplying medical devices and related technologies. Its Class H shares trade on the Hong Kong Stock Exchange under stock code 02291, giving investors exposure to the healthcare and medtech sector in mainland China and the wider region.
Average Trading Volume: 420,162
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.5B
Find detailed analytics on 2291 stock on TipRanks’ Stock Analysis page.